Status History
2026-07-09
OPEN → INELIGIBLE
· This is not a funding programme — the URL leads to an editorial/market-analysis article on entreprisma.fr describing French biotech fundraising trends in 2026 (€3.2 bn raised, named startups, investor commentary). No grant, fellowship, competition, or application mechanism exists on this page. Even if individual programmes mentioned in the article were pursued, all described vehicles (France 2030, BPIFrance, CIR, French VC rounds) are restricted to France-registered entities; the applicant is a Nigerian independent researcher domiciled in Lagos with no French institutional affiliation.